Skip to main content
. 2006 Mar;26(6):2175–2186. doi: 10.1128/MCB.26.6.2175-2186.2006

FIG. 5.

FIG. 5.

(A and B) Intracellular localization of myosin VI is altered in RKO cells by DNA damage in a p53-dependent manner. Parental RKO and RKO-p53-KD cells were mock treated or treated with doxorubicin (DOX). These cells were then stained with anti-p53, anti-myosin VI, and DAPI. (C) Colocalization of myosin VI with trans-Golgi marker TGN p230. Parental RKO cells were mock treated or treated with nutlin or camptothecin (CPT).